Search - tctmd.com

Displaying 41 - 56 of 56

Sort: Relevancy | Date

News Daily News

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Michael O'Riordan

May 05, 2020

News Daily News

Heart Failure Itself, Not Just the Hospital Stay, May Raise Long-term VTE Risk

Caitlin E. Cox

January 14, 2020

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

News Daily News

Diastolic Dysfunction Does Not Negate Health Status Benefits of TAVR

Todd Neale

November 27, 2019

Presentation TCT 2019

Pathophysiology of ADHF: Focus on “Diuretic Resistance”

Presenter: Ileana Pina

September 28, 2019

Presentation TCT 2019

State of the Art: Latest Insights into the Pathophysiology and Medical and Device-Based Therapies for HFpEF

Presenter: Peter Carson

September 28, 2019

Presentation TCT 2019

Clinical Presentation, Pathophysiology, and Natural History

Presenter: Bernard Gersh

September 28, 2019

News Daily News

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

Shelley Wood

May 09, 2019

News Daily News

Elevations in hs-cTnI Linked to Higher Risk of CVD, Particularly Heart Failure

Michael O'Riordan

May 06, 2019

News Daily News

How HF Drugs Help and Harm Female Patients: A Call for Sex-Specific Reporting

Shelley Wood

February 26, 2019

Presentation TCT 2018

Acute Cardiogenic Shock: Pathophysiology and Treatment Goals

Presenter: Cindy L. Grines, E. Magnus Ohman, Timothy D. Henry

September 22, 2018

News Daily News

‘Obesity Paradox’ Is Alive and Well Across Racial/Ethnic Spectrum of Heart Failure Patients

Yael L. Maxwell

February 13, 2018

Presentation TCT 2017

Acute Cardiogenic Shock: Pathophysiology, Hemodynamics, and Treatment Goals

Presenter: Vladimir Dzavik, Navin K. Kapur, Holger Thiele

October 31, 2017

News Daily News

New Guidelines for Cardiogenic Shock Push for Regionalized Care, More Research

Shelley Wood

September 21, 2017

Presentation TCT 2014

CHF and Cardiomyopathy

Presenter: Greg L. Kaluza, Manish A. Parikh, Varinder P. Singh, Allen Jeremias

September 12, 2014

Presentation TCT 2012

HFPEF: Overview of Pathophysiology and Therapies

Presenter: William Little

October 23, 2012

Advertisement

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Heart Failure Itself, Not Just the Hospital Stay, May Raise Long-term VTE Risk

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Diastolic Dysfunction Does Not Negate Health Status Benefits of TAVR

Pathophysiology of ADHF: Focus on “Diuretic Resistance”

State of the Art: Latest Insights into the Pathophysiology and Medical and Device-Based Therapies for HFpEF

Clinical Presentation, Pathophysiology, and Natural History

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

Elevations in hs-cTnI Linked to Higher Risk of CVD, Particularly Heart Failure

How HF Drugs Help and Harm Female Patients: A Call for Sex-Specific Reporting

Acute Cardiogenic Shock: Pathophysiology and Treatment Goals

‘Obesity Paradox’ Is Alive and Well Across Racial/Ethnic Spectrum of Heart Failure Patients

Acute Cardiogenic Shock: Pathophysiology, Hemodynamics, and Treatment Goals

New Guidelines for Cardiogenic Shock Push for Regionalized Care, More Research

CHF and Cardiomyopathy

HFPEF: Overview of Pathophysiology and Therapies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content